Rats were allowed to self-administer solutions of either saline or alcohol (in unit doses of .03, .1, .3, 1.0, and 3.0 mg/kg/ infusionl by both intravenous and intragastric routes. Data from intravenous subjects showed a trend for the number of infusions to decrease and for the amount of drug self-administered to increase with increases in the unit dose made available. Data from the intragastric subjects showed a trend for both number of infusions and amount of drug self-administered to increase with increases in unit dose. Comparison between routes indicated that more infusions were taken, and a greater amount of drug was self-administered with the intravenous route at doses of .1, .3, and 1.0 mg/kg/infusion. However, more intragastric infusions were taken at 3.0 rug/kg/infusion. . 12 mg /kg/infu sion to 200 mg/kg/infusion. While a wide range of doses has been found effective in maintaining self-administration behavior, the attention in the above-cited studies was on variables other than dose; few employed more than a single dose. Thus. directly comparable dose-effect data, within or between routes. are not available. The present research was an attempt to provide such data for the intravenous and the intragastric routes in the rat.
Ethyl alcohol (EA) has been demonstrated to be self-administered both by the intravenous route (Deneau. Yanagita, & Seevers. 1969; Woods, Ikomi, & Winger. 1971; Note 3) . The doses of EA self-injected by the intravenous or intragastric routes ranged from . 12 mg /kg/infu sion to 200 mg/kg/infusion. While a wide range of doses has been found effective in maintaining self-administration behavior, the attention in the above-cited studies was on variables other than dose; few employed more than a single dose. Thus. directly comparable dose-effect data, within or between routes. are not available. The present research was an attempt to provide such data for the intravenous and the intragastric routes in the rat.
METHOD

Subjects
The subjects were adult male rat s of Sprague-Dawley descent. Thirt y rat s were used for Experiment I and 30 for Experiment II . All were drug naive at the start of the experiment . Water and food were available ad lib in both the home cage and experimental chamber throughout the experiment.
Apparatus
Rats for Experiment I were implanted with a chronic indwelling jugular catheter which passed from the jugular vein subcutaneously to an exit on the upper back (for details . see . Rats for Experiment II were surgically prepared with a chronic esophageal intragastric cannula . which passed from the esophagus subcutaneously to an exit on the upper back (for details . see Smith. Werner. & Davis. 1975 The subjects were placed in the test chambers. attached to the injection system . and allowed a l-h period for adaptation to the chambers. Following adaptation. the operant level of leverpressing was determined for a lO-h period during which each response was followed by an intravenous (Experiment 1) or an intragastric (Experiment II) infusion of saline . Superimposed on the infusion interval was a buzzer presentation of equal duration. On each of the subsequent 5 days . a lO-h period of access to either intravenous or intragastric infusions of EA was allowed. The unit doses employed for each route were 0 (saline). .03. . 1, .3. \.0. and 3.0 mg/kg/ infusion . Each experiment employed five different rats at each unit dose . for a total of 30 subjects . Statements concerning statistical comparison between treatments refer to data on Day 5 and are derived from Student's t test using two-tailed probability distribution . Figure 1 shows the number of intravenous infusions taken by subjects at each dose level in Experiment I. The data indicate a trend for reduction in numbers of infusions as the unit dose was increased . Saline and EA, .03 mg /kg /infusion, did not maintain selfadministration and did not differ significantly Comparisons between the intravenous and intragastric routes for number of infusions indicated that more intragastric than intravenous infusions were taken at 3.0 mg/kg /infusion (p < .01). while more infusions were taken by intravenous subjects at . 1•. The general trend for number of infusions by the intravenous subjects was for a decreased number of infusions with increases in the unit dose. An opposite trend was observed for the amount (dosage) self-administered. Number of infusions should be expected to first increase and then decrease with increasing unit dose for intravenous rats. for with the increased unit dose greater effects of satiation and sedation on behavior should result. Also, larger amounts of EA should be self-administered (mg/kg) as the unit dose increases, for subjects at lower unit doses would need to respond 10 to 30 times in order to equ al a single response at the higher doses. On the contrary, the general trend for the intragastric subjects was for increases both in number of infusions and in amount self-administered with increases in unit dose . Evidently, the suppression of responding attributed to sedation and satiation does not occur within this dose range because of the much-delayed absorption and distribution by the intragastric route in contrast to the intravenous route. The patterns described above for intravenous EA are similar to those observed for intravenous morphine (Weeks & Collins, 1971 ; Smith, Werner, & Davis, Note 4) . The patterns described for intragastric EA are similar to those recorded for intragastric medazepam (Gostestam, 1973) .
RESULTS
If one compares the range of intravenous doses at which EA has been found effective, .12 to 200 mg/kg/infusion, to that for morphine sulfate, .03 to 10 mg /kg/infusion, EA appears less potent. Also, if one considers the doses commonly employed in discriminative conditioning research, EA at 1,000-3,000 mg/kg, and morphine at 9-36 mg/kg intraperitoneally, it is quite apparent that EA is much less potent (Overton , 1971) . However, EA is more readily absorbed from the stomach than morphine (Wallgren & Barry, 1971; Reynolds & Randall, 1957) . Thus, intragastric EA should be absorbed so as to produce reinforcing effects significantly sooner than intragastric morphine. Therefore, larger differences should be expected between the two routes for morphine than for alcohol, especially at low and medium doses.
Taking into account the reduced reinforcing effectiveness, discriminative qualities, and satiating and sedating effects of EA, it is not surprising that intravenous EA did surpass intragastric at some dosages. These data would suggest that larger differences between EA unit doses may be required to observe such differences between routes as have been demonstrated for morphine .
